Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2025-12-24 @ 5:08 PM
Study NCT ID:
NCT04385550
Status:
UNKNOWN
Last Update Posted:
2020-05-13
First Post:
2020-05-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-20
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-09
First Submit QC Date:
None
Study First Post Date:
2020-05-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-09
Last Update Post Date:
2020-05-13
Last Update Post Date Type:
ACTUAL